Ioannis Tarnanas - Worldwebforum
Interview with venture case winner Alterniity: We didn't fly too high or too low”
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Loop | Ioannis Tarnanas
Ioannis Tarnanas (@ITarnanas) / Twitter
Ιωάννης Ταρνανάς | Cretalive
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas - Worldwebforum
Greek Researcher Receives Top European Innovation Award
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Κέρκυρα: Πρωτοπόρα εφαρμογή πρόβλεψης Αλτσχάιμερ από βραβευμένους Έλληνες επιστήμονες που διαπρέπουν σε Αμερική σε συνεργασία με το Ιόνιο Πανεπιστήμιο - Έμβολος
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ioannis Tarnanas (@ITarnanas) / Twitter
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
TGL2019 - Dr. Ioannis Tarnanas - YouTube
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia: 9781466682344: Medicine & Health Science Books @ Amazon.com
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas's Page – iACToR
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
